News & Media

We are pleased to share that Joslin has once again been acknowledged by the National Committee for Quality Assurance’s (NCQA) Diabetes Recognition Program (DRP) for the high-quality care provided by...

Renowned businessman was leader in health care philanthropy BOSTON – (September 21, 2020) — Joslin Diabetes Center, an affiliate of Harvard Medical School, mourns the loss of Richard A. “Dick” Smith...

BOSTON – (September 3, 2020) – Using cells taken from patients with type 2 diabetes and new techniques to convert them into specialized precursors of muscle cells, researchers have developed a novel...

Studies in mice offer a proof of concept that ‘HUMBLE’ cells, created from human white fat, can treat metabolic diseases. BOSTON – (August 26, 2020) – Obesity is the main cause of type 2 diabetes and...

An existing drug boosts survival for insulin-producing cells under autoimmune attack. BOSTON – (July 27, 2020) – Type 1 diabetes occurs when a person’s own immune system destroys insulin-producing...

Dr. Jennifer K. Sun, MD, MPH has been promoted to Senior Investigator within the Research Section of the Joslin Diabetes Center. This prestigious appointment recognizes sustained excellence in...

Joslin research in mice and humans shows an adverse effect that begins in pre-diabetes and is independent of obesity. BOSTON – (July 20, 2020) – Every doctor recommends regular aerobic exercise, since...

Study Highlights: Largest US database of pregnant women with type 1 diabetes provides a first-time, big picture view of mother’s health, and neonatal and delivery outcomes. The analysis found a...

Scientists find that reducing levels of uric acid in the blood does not guard against complication in type 1 diabetes. BOSTON – (June 25, 2020) – Historically, half or more of people with type 1...

Study Highlights: Six-month clinical trial shows that continuous glucose monitoring (CGM) helps adolescents and young adults manage their type 1 diabetes more effectively, compared with daily use of...

Multiple populations of subcutaneous white fat cells each may play different roles in obesity, diabetes and other diseases. BOSTON – (May 1, 2020) – Excess white fat causes obesity, which in turn can...

Research in rats identifies surprising effects on hormone production that may accelerate diabetes. BOSTON – (April 16, 2020) – In diabetes, tiny clusters of insulin-producing “beta cells” in the...

BOSTON – (April 6, 2020) – Fatty liver disease not associated with alcohol consumption, which is called Nonalcoholic Fatty Liver Disease or NAFLD, affects more than one billion people worldwide. Even...

­BOSTON -- (March 31, 2002) -- People with type 1 diabetes, particularly those with poor glycemic control, are at markedly increased risk for cardiovascular disease than the general population. Even...

The discovery that immature fat cells can generate heat without gathering fat may open opportunities to treat obesity and diabetes.